FOR IMMEDIATE RELEASE
ACS News Service Weekly PressPac: January 12, 2022
An ice-inspired lubricant improves osteoarthritis symptoms in rats
With the Winter Olympics approaching, many people will soon be tuning in to watch events that take place on ice, such as figure skating, speed skating and ice hockey. An ultrathin, super-lubricating layer of water on the ice’s surface is essential for skaters’ graceful glides. Inspired by this surface, researchers reporting in ACS Nano have developed a treatment for osteoarthritis that enhances lubrication and reduces friction and inflammation in a rat model of the disease.
Osteoarthritis, a chronic disease common in middle-aged and older people, is characterized by persistent inflammation and degeneration of cartilage in the joints. Anti-inflammatory drugs can help relieve pain and inflammation, but long-term use can reduce their effectiveness or cause gastrointestinal problems. Corticosteroids injected directly into the joint provide temporary relief, but frequent treatments can sometimes damage the cartilage. Yuanjin Zhao and colleagues wanted to develop drug delivery particles that, when injected into a joint, could safely enhance lubrication and decrease inflammation.
The researchers based their particles on hyaluronic acid (HA), a natural polysaccharide already used as a lubricant to treat osteoarthritis, but this molecule degrades rapidly inside the body. So the researchers used a microfluidic device to make tiny methacrylate anhydride-HA gel particles, which they reasoned might be stronger and persist longer in the body than an HA solution. To enhance the lubrication of the particles, the team coated them with 2-methylacryloyloxyethyl phosphorylcholine (MPC), which has positively and negatively charged chemical groups that attract a thin layer of water, similar to ice. In addition, the particles’ pores were loaded with an anti-inflammatory drug, which could be slowly and continuously released. The researchers then injected drug-loaded HA-MPC particles into the knee joints of rats with early-stage osteoarthritis. The joints of treated rats were more lubricated and had less cartilage destruction, joint friction and inflammation compared with a control group. The treated rats also expressed higher levels of collagen II and aggrecan, two markers of healthy cartilage. The particles have great potential for clinical applications, but first they must undergo additional animal and biosafety tests, the researchers say.
The authors acknowledge funding from the National Key Research and Development Program of China, the National Natural Science Foundation of China, the Natural Science Foundation of Jiangsu and the Shenzhen Fundamental Research Program.
###
The American Chemical Society (ACS) is a nonprofit organization founded in 1876 and chartered by the U.S. Congress. ACS is committed to improving all lives through the transforming power of chemistry. Its mission is to advance scientific knowledge, empower a global community and champion scientific integrity, and its vision is a world built on science. The Society is a global leader in promoting excellence in science education and providing access to chemistry-related information and research through its multiple research solutions, peer-reviewed journals, scientific conferences, e-books and weekly news periodical Chemical & Engineering News. ACS journals are among the most cited, most trusted and most read within the scientific literature; however, ACS itself does not conduct chemical research. As a leader in scientific information solutions, its CAS division partners with global innovators to accelerate breakthroughs by curating, connecting and analyzing the world’s scientific knowledge. ACS’ main offices are in Washington, D.C., and Columbus, Ohio.
Registered journalists can subscribe to the ACS journalist news portal on EurekAlert! to access embargoed and public science press releases. For media inquiries, contact newsroom@acs.org.
Note: ACS does not conduct research but publishes and publicizes peer-reviewed scientific studies.
Media Contact
ACS Newsroom
newsroom@acs.org
###
La sociedad American Chemical Society (ACS) es una organización sin fines de lucro fundada en 1876 y aprobada por el Congreso de los Estados Unidos. La ACS se ha comprometido a mejorar la vida de todas las personas mediante la transformación del poder de la química. Su misión es promover el conocimiento científico, empoderar a la comunidad global y defender la integridad científica, y su visión es un mundo construido basándose en la ciencia. La Sociedad es líder mundial en la promoción de la excelencia en la educación científica y en el acceso a información e investigación relacionadas con la química a través de sus múltiples soluciones de investigación, publicaciones revisadas por expertos, conferencias científicas, libros electrónicos y noticias semanales periódicas de Chemical & Engineering News. Las revistas de la ACS se encuentran entre las más citadas, las más fiables y las más leídas en la literatura científica; sin embargo, la propia ACS no realiza investigación química. Como líder en soluciones de información científica, su división CAS se asocia con innovadores internacionales para acelerar los avances mediante la preservación, la conexión y el análisis de los conocimientos científicos del mundo. Las sedes principales de la ACS se encuentran en Washington, D.C., y Columbus, Ohio.
Los periodistas registrados pueden suscribirse al portal de noticias para periodistas de ACS en EurekAlert! para acceder a comunicados de prensa públicos y retenidos. Para consultas de los medios, comuníquese con newsroom@acs.org.
Nota: ACS no realiza investigaciones, pero publica y divulga estudios científicos revisados por expertos.
;void(0);){kind=link}